Claus Vogelmeier

German Center for Lung Research — Germany

Medicine · Health Sciences

89h-index54.2kcitations1.1kworks3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research(657), Asthma and respiratory diseases(292), Respiratory Support and Mechanisms(247), Respiratory and Cough-Related Research(143), Inhalation and Respiratory Drug Delivery(74)

Publications1.0k total

Blood eosinopenia (≤30/µL) as an early predictor of respiratory failure in community-acquired pneumonia: A prospective multicentre study
Pulmonology·2026Open Access
TETRIS – Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis
Respiratory Medicine·2025Open Access
Clinical and Economic Burden of COPD in Patients on Inhaled Triple Therapy in Germany – A Retrospective Claims Data Analysis
International Journal of COPD·2025Open Access
Association of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET
International Journal of COPD·2025Open Access
Can Patient Education Lead the Way? Head‐To‐Head Comparison of <scp>EXACT</scp> and <scp>CERT</scp> for Early Recognition of Acute <scp>COPD</scp> Exacerbations
Respirology·2025· 1 citedOpen Access
Addressing the global challenges of COPD and asthma: a shared vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)
European Respiratory Journal·2025· 1 cited
„Schlafen kann ich, wenn ich tot bin!“ – Schlafmedizin im Fokus
Die Innere Medizin·2025Open Access
Addressing the global challenges of chronic obstructive pulmonary disease and asthma: a shared vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA)
American Journal of Respiratory and Critical Care Medicine·2025
Dupilumab efficacy in patients with chronic obstructive pulmonary disease and cardiovascular or metabolic disease: BOREAS and NOTUS
2025
Identification of COPD patients at risk for atrial fibrillation by ECG and its impact on adverse clinical outcomes – a subgroup analysis of the COSYCONET cohort
2025
Efficacy of mepolizumab in patients with COPD &amp; type 2 inflammation: Pooled Phase III trial results
2025
Reduced mortality and cardiopulmonary risk for patients with COPD and asthma when initiating single inhaler triple therapy compared to multiple inhaler triple therapy (MITT): MAZI Asthma Study
2025
Metabolic alterations drive inflammatory phenotypes in CHIP-associated COPD
2025
Late Breaking Abstract - Sustained FEV1 improvements with mepolizumab up to 104 weeks in patients with COPD and less severe airflow obstruction: Post hoc analysis of the MATINEE Phase III study
2025
Late Breaking Abstract - Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO
2025
Small airway disease and early airflow limitation predict onset of COPD: Results from the KORA study
2025
Relationship between the levels of FeNO, blood eosinophils and the severity of exacerbations in patient with COPD: Results from COSYCONET
2025
Late Breaking Abstract - Prevalence of cardiopulmonary events and risk factors before COPD diagnosis: ABACOS RISKS Study
2025
Positive feedback loops as potential contributors to Interleukin-17A-driven synergistic potentiation of inflammatory response and corticosteroid insensitivity
2025
TETRIS: A 24-month, prospective study to observe clinical outcomes in COPD patients with different treatment journeys in Germany
2025
page 1 of 53Next →

Frequent Co-authors

Àlvar Agustí(19), Gerard J. Criner(16), Bartolomé R. Celli(16), Nicolás Roche(15), Robert A. Stockley(13), David Halpin(13), Dave Singh(13), Jørgen Vestbo(12), Antonio Anzueto(12), Leonardo M. Fabbri(12), Fernando J. Martínez(12), Don D. Sin(12), Peter J. Barnes(11), Alberto Papi(11), Jadwiga A. Wedzicha(10), María Victorina López Varela(9), Jean Bourbeau(8), Klaus F. Rabe(8), Roberto Rodríguez-Roisin(7), Marc Decramer(7)